NYSE: ECGEverus Construction Group Inc Stock
$38.05+0.26 (+0.69%)
Updated Mar 14, 2025
ECG Price
$38.05
Fair Value Price
N/A
Market Cap
$1.94B
52 Week Low
$37.00
52 Week High
$77.93
P/E
13.54x
P/B
4.59x
P/S
1.18x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.85B
Earnings
$143.42M
Gross Margin
11.9%
Operating Margin
7.26%
Profit Margin
5%
Debt to Equity
2.05
Operating Cash Flow
$163M
Beta
1.94
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ECG's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Construction
Industry Rating
B
ECG
Ranked#2 of 22
Ranked#2 of 22
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $506.83 | A | |
| $58.69 | B | |
| $117.22 | B |
Be the first to know about important ECG news, forecast changes, insider trades & much more!
ECG News
Overview
Due Diligence Score
–
Industry Average (36)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ECG scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ECG is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ECG is good value based on its earnings relative to its share price (13.54x), compared to the US market average (3,446.61x)
P/E vs Market Valuation
ECG is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more ECG due diligence checks available for Premium users.
Valuation
ECG price to earnings (PE)
For valuing profitable companies with steady earnings
Company
13.54x
Industry
10.05x
Market
3,446.61x
ECG is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ECG is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
ECG price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.59x
Industry
1.54x
ECG is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ECG's financial health
Profit margin
Revenue
$759.6M
Net Income
$34.5M
Profit Margin
4.5%
ECG's Earnings (EBIT) of $206.97M... subscribe to Premium to read more.
Interest Coverage Financials
ECG's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.3B
Liabilities
$865.9M
Debt to equity
2.05
ECG's short-term assets ($917.23M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ECG's short-term assets ($917.23M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ECG's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$80.7M
Investing
-$11.6M
Financing
$16.3M
ECG's operating cash flow ($163.38M)... subscribe to Premium to read more.
Debt Coverage Financials
ECG vs Construction Stocks
Everus Construction Group Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.